Category: Cornea

The CLEI Center for Keratoconus is world-renowned for innovating and improving upon corneal surgical techniques. One such technique is corneal tissue addition keratoplasty (CTAK). Unlike treatments that simply focus on addressing refractive errors, CTAK was envisioned as a procedure that could address the underlying structural irregularities associated with keratoconus. In 2016, clinical trials for this […]

What is Corneal Crosslinking? Collagen is a crucial protein found throughout our bodies, providing strength and support to various tissues, including corneal tissue. However, for patients with keratoconus, the collagen fibers in the cornea weaken and become susceptible to deformation. The compromised corneal tissue eventually loses its symmetrical dome shape, bulging outwards and resulting in […]

Understanding Keratoconus and the Need for Surgical Intervention Keratoconus is a progressive eye condition where the cornea, the clear front part of the eye, thins and bulges into a cone-like shape. This irregular shape can cause significant vision problems, including blurred and distorted vision, sensitivity to light and glare, and difficulty driving at night. While […]

Corneal crosslinking (CXL) is a procedure designed to strengthen the cornea, the clear front part of your eye. It’s used to treat conditions like keratoconus and post refractive surgery corneal ectasia. Both are progressive eye diseases that can cause your cornea to thin and bulge. While CXL is a safe and effective procedure, it’s important […]

Introduction to Keratoconus and the Need for Effective Treatments Keratoconus is a progressive eye condition that affects the shape and structure of the cornea, the clear dome-shaped front surface of the eye. This condition causes the cornea to thin and bulge, resulting in distorted vision. It typically begins during adolescence or early adulthood and can […]

Keratoconus, a progressive eye condition characterized by the thinning and bulging of the cornea, presents a significant challenge in the field of ophthalmology. For individuals afflicted with this disorder, the distorted shape of the cornea can lead to visual impairment and a diminished quality of life. While traditional treatments such as glasses, specialty contact lenses, […]

Corneal Tissue Addition Keratoplasty (CTAK) is a novel tissue addition technique that improves corneal curvature and vision for patients with keratoconus. Keratoconus is characterized by thinning of the cornea resulting in a steep cone shape and irregular astigmatism. In technical terms, CTAK is a form of lamellar keratoplasty where a customized sterilized corneal stromal inlay […]

Epi-off corneal collagen cross-linking (CXL) treatment treats progressive keratoconus and ectasia that develops after refractive surgery. The procedure received FDA approval in 2016. Dr. Greenstein and his colleagues conducted a study to determine how well the procedure faired over the years. The study concluded that the treatment appears to remain stable for the majority of […]

The Cornea and Laser Eye Institute is proud to sponsor the NJ Regional Horse Trials that were held on June 2, 2018! Julia Hersh, who is a very active participant is volunteering at this event.  We look forward to participating in more events in the future! Good luck everyone and more importantly, have fun! https://www.njregionponyclub.org/nj-regions-horse-trials—6-3-2018.html

Avedro Announces FDA Priority Review Status! – Corneal Cross-linking! This is huge news for the keratoconic community. The priority review status for the New Drug Application (NDA) places the application action date at March 15th, 2014.